Back to Search Start Over

Neuroprotective effects of mildronate in a rat model of traumatic brain injury.

Authors :
Demir, Dilan
Kuru Bektaşoğlu, Pınar
Koyuncuoğlu, Türkan
Kandemir, Cansu
Akakın, Dilek
Yüksel, Meral
Çelikoğlu, Erhan
Yeğen, Berrak Ç
Gürer, Bora
Source :
Injury. Oct2019, Vol. 50 Issue 10, p1586-1592. 7p.
Publication Year :
2019

Abstract

<bold>Objective: </bold>Traumatic brain injury (TBI) is one of the most common preventable causes of mortality and morbidity. Inflammation, apoptosis, oxidative stress, and ischemia are some of the important pathophysiological mechanisms underlying neuronal loss after TBI. Mildronate is demonstrated to be beneficial in various experimental models of ischemic diseases via anti-inflammatory, antioxidant, and neuroprotective mechanisms. This study aimed to investigate possible antioxidant, anti-inflammatory, antiapoptotic, and neuroprotective effects of mildronate in a rat model of TBI.<bold>Methods: </bold>A total of 46 male rats were divided into three groups of control, saline-treated TBI, and mildronate-treated TBI. Both TBI groups were subjected to closed-head contusive weight-drop injuries followed by treatment with saline or mildronate (100 mg/kg) administered intraperitoneally. The forebrain was removed 24 h after trauma induction, the activities of myeloperoxidase (MPO) and caspase-3, levels of superoxide dismutase (SOD), luminol- and lucigenin-enhanced chemiluminescence were measured, and histomorphological evaluation of cerebral tissues was performed.<bold>Results: </bold>Increased MPO and caspase-3 activities in the vehicle-treated TBI group (p < 0.001) were suppressed in the mildronate-treated TBI group (p < 0.001). Similarly, increase in luminol and lucigenin levels (p < 0.001 and p < 0.01, respectively) in the vehicle-treated TBI group were decreased in the mildronate-treated TBI group (p < 0.001). Concomitantly, in the vehicle-treated TBI group, TBI-induced decrease in SOD activity (p < 0.01) was reversed with mildronate treatment (p < 0.05). On histopathological examination, TBI-induced damage in the cerebral cortex was lesser in the mildronate-treated TBI group than that in other groups.<bold>Conclusion: </bold>This study revealed for the first time that mildronate, exhibits neuroprotective effects against TBI because of its anti-inflammatory, antiapoptotic, and antioxidant activities. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00201383
Volume :
50
Issue :
10
Database :
Academic Search Index
Journal :
Injury
Publication Type :
Academic Journal
Accession number :
139559515
Full Text :
https://doi.org/10.1016/j.injury.2019.08.036